Castro Valley, CA, United States of America

Joseph Michael Young

USPTO Granted Patents = 17 (Patent Applications = 9)

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 5 (Patent Applications = 10)

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 92(Granted Patents)

Location History:

Pasadena, CA (US) (1992 - 1999)
Erie, PA (US) (2001)
Madison, CT (US) (2017 - 2018)
Castro Valley, CA (US) (2017 - 2022)
Emeryville, CA (US) (2023)
Pleasant Hill, CA (US) (2019 - 2024)

Company Filing History:

Gilead Sciences, Inc.

patents

4. 1 out of 832,680

Other

patents

Years Active: 1992-2025

Loading Chart...

17 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12338220 - Antiviral pyrazolopiridinone compounds (2025-06-24),

2. 12018024 - Compounds and compositions for the treatment of cryptosporidiosis (2024-06-25),

3. 11667613 - Antiviral pyrazolopyridinone compounds (2023-06-06),

4. 11390623 - 6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands (2022-07-19),

5. 11234977 - Fused tricyclic pyrazolo-dihydropyrazinyl-pyridone compounds as antivirals (2022-02-01),

6. 10975078 - Fused indazole pyridone compounds as antivirals (2021-04-13),

7. 10669279 - Imidazopyridazine compounds (2020-06-02),

8. 10590128 - 6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands (2020-03-17),

9. 10301312 - Fused indazole pyridone compounds as antivirals (2019-05-28),

10. 10131669 - Pyrazolopyrimidine compounds (2018-11-20),

11. 10093673 - Tetracyclic pyridone compounds as antivirals (2018-10-09),

12. 10077269 - Imidazopyridazine compounds (2018-09-18),

13. 9845325 - Tetracyclic pyridone compounds as antivirals (2017-12-19),

14. 9598421 - Imidazopyridazine compounds (2017-03-21),

15. 6319084 - Sound simulating method and device (2001-11-20),

Title: The Inventor Profile: Joseph Michael Young

Introduction:

Joseph Michael Young, a prolific inventor based in Castro Valley, CA, has made significant contributions to the field of pharmaceuticals with his innovative patents. With a total of 12 patents to his name, Joseph Young's work stands out for its impact on treating viral infections and disorders associated with dopamine D3.

Latest Patents:

Joseph Young's latest patents showcase his expertise in developing novel treatments for various health conditions. One of his recent patents involves antiviral pyrazolopyridinone compounds, which are aimed at combating viral infections, especially those caused by herpesviruses. Additionally, his invention of 6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands offers promising possibilities in treating D3-mediated disorders like substance addiction, schizophrenia, and depression.

Career Highlights:

Having worked with renowned companies such as Novartis AG and Pfizer Corporation, Joseph Young has honed his skills and knowledge in the pharmaceutical industry. His expertise and dedication have led to the development of groundbreaking pharmaceutical compounds that have the potential to revolutionize the treatment of various health conditions.

Collaborations:

Throughout his career, Joseph Young has collaborated with esteemed professionals in the field, including Thomas Allen Chappie and Patrick Robert Verhoest. These collaborations have not only enriched his work but have also facilitated the exchange of ideas and insights that have fueled innovation in the pharmaceutical sector.

Conclusion:

In conclusion, Joseph Michael Young's inventive spirit and commitment to advancing pharmaceutical research have significantly impacted the field of medicine. His patents reflect a deep understanding of complex health conditions and a drive to discover effective treatments. Joseph Young's contributions continue to inspire and pave the way for future advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.